IRVINE,
Calif., May 13, 2024 /PRNewswire/ -- American
Healthcare REIT, Inc. (the "Company," "we," "our," or "us")
(NYSE: AHR) announced today its first quarter 2024 results.
Key Highlights:
- Reported GAAP net loss attributable to common stockholders of
$(0.04) per basic and diluted share
for the three months ended March 31,
2024.
- Reported Normalized Funds from Operations attributable to
common stockholders ("NFFO") of $0.30
per basic and diluted share for the three months ended March 31, 2024.
- Achieved 7.1% total portfolio Same-Store ("SS") revenue growth
for the three months ended March 31,
2024 compared to the same period in 2023, largely driven by
improved performance in the Company's RIDEA-operated assets.
- Achieved total portfolio Same-Store Net Operating Income
("NOI") growth of 13.0% for the three months ended March 31, 2024 compared to the same period in
2023, highlighted by 33.5% and 19.9% Same-Store NOI growth from its
senior housing operating properties ("SHOP") and integrated senior
health campuses ("ISHC"), respectively.
- Disposed of approximately $15.6
million of Non-Core Properties across the Company's
outpatient medical ("OM") and SHOP segments.
- Acquired a 14-property portfolio in Oregon for approximately $94.5 million that is managed by Compass Senior
Living in a RIDEA structure.
- Completed a public offering of 64.4 million shares of its
common stock priced at a public offering price of $12.00 per share and listed such common stock on
the New York Stock Exchange ("NYSE") under the symbol "AHR".
- Paid down approximately $721.5
million of outstanding debt obligations carrying a weighted
average interest rate of approximately 7.5%, substantially
improving leverage metrics and providing the Company with
additional borrowing capacity and flexibility.
"After completing our offering and listing event in February,
our main focus is on delivering strong operating performance across
our property segments. The year is off to a solid start, as we
captured outsized growth within our RIDEA-operated assets due to
the supply-demand imbalance present in the senior housing industry.
Our assets are well positioned and staffed appropriately to
capitalize on further near-term demand tailwinds, which we believe
will drive additional occupancy gains and rate growth," said
Danny Prosky, the Company's
President and Chief Executive Officer.
First Quarter 2024 Results
The Company's active asset management continues to strengthen
top-line growth, in addition to effectively managing controllable
expenses. In aggregate, NOI growth remains on track to achieve the
growth contemplated within the Company's 2024 total portfolio
Same-Store NOI growth guidance range.
SS NOI Growth Rates:
Quarter Ended March 31, 2024 Relative to Quarter Ended March 31,
2023
|
Segment
|
NOI
Growth
|
ISHC
OM
SHOP
Triple-Net Leased
Properties
Total
Portfolio
|
19.9%
1.0%
33.5%
4.3%
13.0%
|
"Our hands-on active asset management approach is proving its
merits, as evidenced by the stellar performance of our recently
acquired Oregon portfolio. After
only two months of owning and operating the portfolio, with Compass
Senior Living as our operating partner, the properties have
meaningfully improved bottom-line performance and, while still
early, are trending ahead of our initial expectations," said
Gabe Willhite, the Company's Chief
Operating Officer.
Full Year 2024 Guidance
The Company's following guidance ranges for the year ending
December 31, 2024, originally
announced on March 21, 2024 in the
Company's Fourth Quarter 2023 Earnings Release, remain
unchanged:
|
Full Year 2024
Guidance
|
Metric
|
FY 2024
Range
|
FY 2024
Midpoint
|
NAREIT FFO per
share
NFFO per
share
Total Portfolio SS NOI
Growth
Segment-Level SS NOI
Growth / (Decline):
ISHC
OM
SHOP
Triple-Net Leased
Properties
|
$1.13 to
$1.19
$1.18 to
$1.24
5.0% to 7.0%
8.0% to
10.0%
(0.5)% to
0.0%
25.0% to
30.0%
1.0% to 3.0%
|
$1.16
$1.21
6.0%
9.0%
(0.3)%
27.5%
2.0%
|
Certain of the
assumptions underlying the Company's 2024 guidance can be found
within the Non-GAAP reconciliations in this earnings release and in
the appendix of the Company's First Quarter 2024 Supplemental
Financial Information ("Supplemental"). A reconciliation of Net
Loss calculated in accordance with GAAP to NAREIT FFO and NFFO can
be found within the Non-GAAP reconciliations in this earnings
release. Non-GAAP financial measures and other terms, as used in
this earnings release, are also defined and further explained in
the Supplemental. The Company does not provide guidance for the
most comparable GAAP financial measures of total revenues and
property operating and maintenance expenses. Additionally, a
reconciliation of the forward-looking non-GAAP financial measures
of Same-Store NOI growth to the comparable GAAP financial measures
cannot be provided without unreasonable effort because the Company
is unable to reasonably predict certain items contained in the GAAP
measures, including non-recurring and infrequent items that are not
indicative of the Company's ongoing operations. Such items include,
but are not limited to, impairment on depreciated real estate
assets, net (gain)/loss on sale of previously depreciated real
estate assets, stock-based compensation, casualty loss,
non-Same-Store revenues, and non-Same-Store operating expenses.
These items are uncertain, depend on various factors, and could
have a material impact on the Company's GAAP results for the
guidance period.
|
Transaction Activity
As previously announced, on February 1,
2024, the Company acquired a senior housing portfolio in
Oregon consisting of 856 beds
across 14 properties. The total consideration consisted of
approximately $94.5 million of
assumed debt, plus closing costs, reflecting a price per bed of
approximately $110,000. The assumed
debt has a fixed interest rate of 4.54% and matures on January 1, 2028. The portfolio is managed by
Compass Senior Living through a RIDEA structure. The Company has a
longstanding relationship with Compass Senior Living as a tenant in
its triple-net leased properties segment and recognized the
strength of the operator through the COVID-19 pandemic. The
management agreement is the Company's first RIDEA structure with
Compass Senior Living, expanding the Company's high-quality
operator relationships.
Additionally, during the three months ended March 31, 2024, the Company disposed of two
Non-Core OM buildings and one Non-Core SHOP facility for
approximately $15.6 million in
aggregate gross proceeds, of which $11
million was previously announced.
Subsequent to quarter end, through the Company's Trilogy REIT
Holdings investment, the Company redeemed all the remaining equity
interests in Trilogy owned by members of Trilogy management and
certain members of Trilogy's advisory committee. As a result, as of
April 15, 2024, the Company owns 76%
of Trilogy. As previously reported, the Company also has an
option to purchase the remaining 24% of Trilogy that is owned by a
joint venture partner until September 30,
2025 at a predetermined price.
Capital Markets and Balance Sheet Activity
As previously announced, during the three months ended
March 31, 2024, the Company completed
a public offering of 64.4 million shares of its common stock,
raising gross offering proceeds of $772.8
million, and listed such common stock on the NYSE under the
symbol "AHR". During the quarter, the Company paid down
approximately $721.5 million of
outstanding debt with a weighted average interest rate of
approximately 7.5%. This significant reduction in outstanding debt
improved the Company's leverage by meaningfully reducing near-term
maturities and high-interest floating-rate debt. Additionally,
during the quarter the Company amended its existing credit
facility, extending its maturity date and increasing its borrowing
capacity to up to $1.15 billion. The
credit facility consists of an unsecured revolving credit facility
in the initial aggregate amount of $600
million and an unsecured term loan facility in the initial
aggregate amount of $550 million. The
revolving portion of the credit facility now matures on
February 14, 2028, and may be
extended for one 12-month period, subject to certain conditions,
and the term loan portion of the facility matures on January 19, 2027.
As of March 31, 2024, the
Company's total Pro-Rata indebtedness was $1.75 billion, and the Company had approximately
$914.5 million of total
consolidated liquidity comprised of cash and undrawn capacity on
its lines of credit.
"Utilizing proceeds from our public offering in February, we
were able to pay down floating-rate indebtedness, bringing our
net-debt-to-Adjusted EBITDA ratio down to 6.4x at the end of the
first quarter. We believe that the organic earnings growth embedded
in our previously announced Normalized FFO and Same-Store portfolio
guidance for the remainder of the year should result in further
improvement to our leverage ratios," said Brian Peay, the Company's Chief Financial
Officer.
Distribution
As previously announced, the Company's Board of Directors
declared a cash distribution for the quarter ended March 31, 2024 of $0.25 per share of its common stock, Class T
common stock and Class I common stock. The first quarter
distribution was paid in cash on April 19,
2024 to stockholders of record as of March 28, 2024.
Supplemental Information
The Company has disclosed supplemental information regarding its
portfolio, financial position and results of operations as of
March 31, 2024 and for the quarter
then ended and certain other information, which is available on the
Company's website at https://ir.americanhealthcarereit.com.
Conference Call and Webcast Information
The Company will host a webcast and conference call at
1:00 p.m. Eastern Time on
May 14, 2024. During the conference
call, Company executives will review first quarter 2024 results,
discuss recent events and conduct a question-and-answer period.
To join via webcast, investors may use the following link:
https://events.q4inc.com/attendee/167736636.
Alternatively, to join via telephone, please pre-register at the
following link.
A digital replay of the call will be available on our website at
https://ir.americanhealthcarereit.com shortly after the conclusion
of the call.
Forward-Looking Statements
Certain statements contained in this press release, including
statements relating to the Company's expectations regarding its
interest expense savings, balance sheet, net income or loss per
share, FFO per share, NFFO per share, total portfolio Same-Store
NOI growth, segment-level Same-Store NOI growth, occupancy, NOI
growth, revenue growth, margin expansion and plans for Trilogy may
be considered forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. The Company
intends for all such forward-looking statements to be covered by
the applicable safe harbor provisions for forward-looking
statements contained in those acts. Such forward-looking statements
generally can be identified by the use of forward-looking
terminology, such as "may," "will," "can," "expect," "intend,"
"anticipate," "estimate," "believe," "continue," "possible,"
"initiatives," "focus," "seek," "objective," "goal," "strategy,"
"plan," "potential," "potentially," "preparing," "projected,"
"future," "long-term," "once," "should," "could," "would," "might,"
"uncertainty" or other similar words. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date of this press release. Any such
forward-looking statements are based on current expectations,
estimates and projections about the industry and markets in which
the Company operates, and beliefs of, and assumptions made by, the
Company's management and involve known and unknown risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied therein, including, without
limitation, risks disclosed in the Company's periodic reports filed
with the Securities and Exchange Commission. Except as required by
law, the Company does not undertake any obligation to update or
revise any forward-looking statements contained in this
release.
Non-GAAP Financial Measures
The Company's reported results are presented in accordance with
GAAP. The Company also discloses the following non-GAAP financial
measures: NAREIT FFO, NFFO, NOI, Same-Store NOI, EBITDA and
Adjusted EBITDA. The Company believes these non-GAAP financial
measures are useful supplemental measures of its operating
performance and used by investors and analysts to compare the
operating performance of the Company between periods and to other
REITs or companies on a consistent basis without having to account
for differences caused by unanticipated and/or incalculable items.
Definitions of the non-GAAP financial measures used herein and
reconciliations to the most directly comparable financial measure
calculated in accordance with GAAP can be found at the end of this
earnings release.
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc. is a self-managed real estate
investment trust that acquires, owns and operates a diversified
portfolio of clinical healthcare real estate properties, focusing
primarily on outpatient medical buildings, senior housing, skilled
nursing facilities and other healthcare-related facilities. Its
properties are located in 36 states, the United Kingdom and the Isle of Man. For additional information,
please visit www.AmericanHealthcareREIT.com.
AMERICAN HEALTHCARE
REIT, INC.
CONDENSED
CONSOLIDATED BALANCE SHEETS
As of March 31, 2024
and December 31, 2023
(In thousands)
(Unaudited)
|
|
|
March 31,
2024
|
|
December 31,
2023
|
ASSETS
|
Real estate
investments, net
|
$
3,478,773
|
|
$
3,425,438
|
Debt security
investment, net
|
87,984
|
|
86,935
|
Cash and cash
equivalents
|
77,026
|
|
43,445
|
Restricted
cash
|
47,505
|
|
47,337
|
Accounts and other
receivables, net
|
215,881
|
|
185,379
|
Identified intangible
assets, net
|
187,814
|
|
180,470
|
Goodwill
|
234,942
|
|
234,942
|
Operating lease
right-of-use assets, net
|
221,575
|
|
227,846
|
Other assets,
net
|
151,930
|
|
146,141
|
Total
assets
|
$
4,703,430
|
|
$
4,577,933
|
|
|
|
|
LIABILITIES,
REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY
|
Liabilities:
|
|
|
|
Mortgage loans
payable, net
|
$
1,228,435
|
|
$
1,302,396
|
Lines of credit and
term loan, net
|
759,308
|
|
1,223,967
|
Accounts payable and
accrued liabilities
|
257,283
|
|
242,905
|
Identified intangible
liabilities, net
|
5,805
|
|
6,095
|
Financing
obligations
|
41,101
|
|
41,756
|
Operating lease
liabilities
|
219,767
|
|
225,502
|
Security deposits,
prepaid rent and other liabilities
|
48,933
|
|
76,134
|
Total
liabilities
|
2,560,632
|
|
3,118,755
|
|
|
|
|
Commitments and
contingencies
|
|
|
|
|
|
|
|
Redeemable
noncontrolling interests
|
11,636
|
|
33,843
|
|
|
|
|
Equity:
|
|
|
|
Stockholders'
equity:
|
|
|
|
Preferred stock,
$0.01 par value per share; 200,000,000 shares authorized;
none
issued and outstanding
|
—
|
|
—
|
Common Stock, $0.01
par value per share; 700,000,000 shares authorized;
65,372,222 shares issued and outstanding as of March 31, 2024 and
none
issued and outstanding as of December 31, 2023
|
644
|
|
—
|
Class T common stock,
$0.01 par value per share; 200,000,000 shares
authorized;
19,552,425 and 19,552,856 shares issued and outstanding as of March
31, 2024
and December 31, 2023, respectively
|
194
|
|
194
|
Class I common stock,
$0.01 par value per share; 100,000,000 shares
authorized;
46,673,320 shares issued and outstanding as of both March 31, 2024
and
December 31, 2023
|
467
|
|
467
|
Additional paid-in
capital
|
3,275,252
|
|
2,548,307
|
Accumulated
deficit
|
(1,313,190)
|
|
(1,276,222)
|
Accumulated other
comprehensive loss
|
(2,468)
|
|
(2,425)
|
Total stockholders'
equity
|
1,960,899
|
|
1,270,321
|
Noncontrolling
interests
|
170,263
|
|
155,014
|
Total
equity
|
2,131,162
|
|
1,425,335
|
Total liabilities,
redeemable noncontrolling interests and equity
|
$
4,703,430
|
|
$
4,577,933
|
AMERICAN HEALTHCARE
REIT, INC.
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS
For the Three Months
Ended March 31, 2024 and 2023
(In thousands,
except share and per share amounts) (Unaudited)
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
Revenues:
|
|
|
|
Resident fees and
services
|
$
452,118
|
|
$
408,630
|
Real estate
revenue
|
47,415
|
|
43,596
|
Total
revenues
|
499,533
|
|
452,226
|
Expenses:
|
|
|
|
Property operating
expenses
|
403,629
|
|
370,146
|
Rental
expenses
|
13,727
|
|
15,195
|
General and
administrative
|
11,828
|
|
13,053
|
Business acquisition
expenses
|
2,782
|
|
332
|
Depreciation and
amortization
|
42,767
|
|
44,670
|
Total
expenses
|
474,733
|
|
443,396
|
Other income
(expense):
|
|
|
|
Interest
expense:
|
|
|
|
Interest expense
(including amortization of deferred financing costs,
debt discount/premium and loss on
debt extinguishments)
|
(36,438)
|
|
(39,011)
|
Gain (loss) in fair
value of derivative financial instruments
|
6,417
|
|
(195)
|
Gain (loss) on
dispositions of real estate investments, net
|
2,263
|
|
(132)
|
Loss from
unconsolidated entities
|
(1,205)
|
|
(306)
|
Gain on re-measurement
of previously held equity interest
|
—
|
|
726
|
Foreign currency
(loss) gain
|
(426)
|
|
1,008
|
Other
income
|
1,863
|
|
1,608
|
Total net other
expense
|
(27,526)
|
|
(36,302)
|
Loss before income
taxes
|
(2,726)
|
|
(27,472)
|
Income tax
expense
|
(278)
|
|
(143)
|
Net
loss
|
(3,004)
|
|
(27,615)
|
Net (income) loss
attributable to noncontrolling interests
|
(888)
|
|
1,743
|
Net loss
attributable to controlling interest
|
$
(3,892)
|
|
$
(25,872)
|
Net loss per share
of Common Stock, Class T common stock and Class I
common
stock attributable to
controlling interest — basic and diluted
|
$
(0.04)
|
|
$
(0.39)
|
Weighted average
number of shares of Common Stock, Class T common stock
and
Class I common stock
outstanding — basic and diluted
|
104,295,142
|
|
66,026,173
|
|
|
|
|
Net loss
|
$
(3,004)
|
|
$
(27,615)
|
Other comprehensive
(loss) income:
|
|
|
|
Foreign currency
translation adjustments
|
(43)
|
|
122
|
Total other
comprehensive (loss) income
|
(43)
|
|
122
|
Comprehensive
loss
|
(3,047)
|
|
(27,493)
|
Comprehensive (income)
loss attributable to noncontrolling interests
|
(888)
|
|
1,743
|
Comprehensive loss
attributable to controlling interest
|
$
(3,935)
|
|
$
(25,750)
|
AMERICAN HEALTHCARE
REIT, INC.
FFO and Normalized
FFO Reconciliation
For the Three Months
Ended March 31, 2024 and 2023
(In thousands,
except share and per share amounts) (Unaudited)
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
Net loss
|
$
(3,004)
|
|
$
(27,615)
|
Depreciation and
amortization related to real estate — consolidated
properties
|
42,729
|
|
44,632
|
Depreciation and
amortization related to real estate — unconsolidated
entities
|
186
|
|
63
|
(Gain) loss on
dispositions of real estate investments, net — consolidated
properties
|
(2,263)
|
|
132
|
Net (income) loss
attributable to noncontrolling interests
|
(888)
|
|
1,743
|
Gain on re-measurement
of previously held equity interest
|
—
|
|
(726)
|
Depreciation,
amortization, impairments, net gain/loss on dispositions and gain
on
re-measurement — noncontrolling interests
|
(5,462)
|
|
(6,538)
|
NAREIT FFO attributable
to controlling interest
|
$
31,298
|
|
$
11,691
|
|
|
|
|
Business acquisition
expenses
|
$
2,782
|
|
$
332
|
Amortization of above-
and below-market leases
|
426
|
|
8,675
|
Amortization of closing
costs — debt security investments
|
76
|
|
65
|
Change in deferred
rent
|
(589)
|
|
(60)
|
Non-cash impact of
changes to equity instruments
|
1,935
|
|
1,072
|
Capitalized
interest
|
(134)
|
|
(26)
|
Loss on debt
extinguishments
|
1,280
|
|
—
|
(Gain) loss in fair
value of derivative financial instruments
|
(6,417)
|
|
195
|
Foreign currency loss
(gain)
|
426
|
|
(1,008)
|
Adjustments for
unconsolidated entities
|
(110)
|
|
(74)
|
Adjustments for
noncontrolling interests
|
125
|
|
(633)
|
Normalized FFO
attributable to controlling interest
|
$
31,098
|
|
$
20,229
|
Weighted average common
shares outstanding — basic and diluted
|
104,295,142
|
|
66,026,173
|
Net loss per common
share attributable to controlling interest — basic and
diluted
|
$
(0.04)
|
|
$
(0.39)
|
NAREIT FFO per common
share attributable to controlling interest — basic and
diluted
|
$
0.30
|
|
$
0.18
|
Normalized FFO per
common share attributable to controlling interest — basic and
diluted
|
$
0.30
|
|
$
0.31
|
AMERICAN HEALTHCARE
REIT, INC.
Adjusted EBITDA
Reconciliation
For the Three Months
Ended March 31, 2024
(In thousands)
(Unaudited)
|
|
|
Net loss
|
$
(3,004)
|
|
|
Adjustments:
|
|
Loss from
unconsolidated entities
|
1,205
|
Interest expense
(including amortization of deferred financing costs,
debt
discount/premium and loss on debt extinguishments)
|
36,438
|
Income tax
expense
|
278
|
Depreciation and
amortization (including amortization of
above/below
market leases and right-of-use assets and accretion of lease
liabilities)
|
43,784
|
Straight line
rent
|
(1,132)
|
Foreign currency
loss
|
426
|
Gain in fair value of
derivative financial instruments
|
(6,417)
|
EBITDA
|
$
71,578
|
|
|
Non-cash stock-based
compensation expense
|
1,935
|
Business acquisition
expenses
|
2,782
|
Gain on dispositions of
real estate investments, net
|
(2,263)
|
Non-recurring one-time
items
|
212
|
|
|
Adjusted
EBITDA
|
$
74,244
|
AMERICAN HEALTHCARE
REIT, INC.
Cash NOI
Reconciliation
For the Three Months
Ended March 31, 2024 and 2023
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
Net loss
|
$
(3,004)
|
|
$
(27,615)
|
General and
administrative
|
11,828
|
|
13,053
|
Business acquisition
expenses
|
2,782
|
|
332
|
Depreciation and
amortization
|
42,767
|
|
44,670
|
Interest
expense
|
36,438
|
|
39,011
|
(Gain) loss in fair
value of derivative financial instruments
|
(6,417)
|
|
195
|
(Gain) loss on
dispositions of real estate investments, net
|
(2,263)
|
|
132
|
Loss from
unconsolidated entities
|
1,205
|
|
306
|
Gain on re-measurement
of previously held equity interests
|
—
|
|
(726)
|
Foreign currency loss
(gain)
|
426
|
|
(1,008)
|
Other income
|
(1,863)
|
|
(1,608)
|
Income tax
expense
|
278
|
|
143
|
Total NOI
|
$
82,177
|
|
$
66,885
|
|
|
|
|
Straight line
rent
|
(1,132)
|
|
(1,090)
|
Facility rental
expense
|
8,840
|
|
9,645
|
Other non-cash
adjustments
|
391
|
|
8,614
|
COVID
subsidies
|
—
|
|
(143)
|
Consolidated Cash
NOI
|
$
90,276
|
|
$
83,911
|
|
|
|
|
Cash NOI attributable
to noncontrolling interest (1)
|
(12,714)
|
|
(10,789)
|
Pro-Rata Cash
NOI
|
$
77,562
|
|
$
73,122
|
|
|
|
|
|
|
|
|
(1)
|
All quarters are based
upon ownership percentage as of the most recent quarter
end.
|
AMERICAN HEALTHCARE
REIT, INC.
Same-Store NOI
Reconciliation
For the Three Months
Ended March 31, 2024 and 2023
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
ISHC
|
|
|
|
NOI
|
$
41,980
|
|
$
33,409
|
Facility rental
expense
|
8,840
|
|
9,645
|
Cash NOI attributable
to noncontrolling interest (1)
|
(12,484)
|
|
(10,577)
|
Cash NOI
|
$
38,336
|
|
$
32,477
|
New
acquisitions/dispositions/transitions
|
(4,844)
|
|
(4,554)
|
Same-Store
NOI
|
$
33,492
|
|
$
27,923
|
|
|
|
|
Outpatient
Medical
|
|
|
|
NOI
|
$
20,978
|
|
$
23,075
|
Straight line
rent
|
(158)
|
|
(393)
|
Other non-cash
adjustments
|
164
|
|
187
|
Cash NOI
|
$
20,984
|
|
$
22,869
|
New
acquisitions/dispositions/transitions
|
(75)
|
|
(2,247)
|
Non-Core
Properties
|
(834)
|
|
(752)
|
Same-Store
NOI
|
$
20,075
|
|
$
19,870
|
|
|
|
|
SHOP
|
|
|
|
NOI
|
$
6,509
|
|
$
5,075
|
Other non-cash
adjustments
|
—
|
|
(40)
|
COVID
subsidies
|
—
|
|
(143)
|
Cash NOI attributable
to noncontrolling interest (1)
|
(46)
|
|
(30)
|
Cash NOI
|
$
6,463
|
|
$
4,862
|
New
acquisitions/dispositions/transitions
|
784
|
|
557
|
Development
conversion
|
540
|
|
412
|
Same-Store
NOI
|
$
7,787
|
|
$
5,831
|
|
|
|
|
Triple-Net Leased
Properties
|
|
|
|
NOI
|
$
12,710
|
|
$
5,326
|
Straight line
rent
|
(974)
|
|
(697)
|
Other non-cash
adjustments
|
227
|
|
8,467
|
Cash NOI attributable
to noncontrolling interest (1)
|
(184)
|
|
(182)
|
Cash NOI
|
$
11,779
|
|
$
12,914
|
Debt security
investment
|
(2,081)
|
|
(1,970)
|
New
acquisitions/dispositions/transitions
|
—
|
|
(1,653)
|
Non-Core
Properties
|
(373)
|
|
(352)
|
Same-Store
NOI
|
$
9,325
|
|
$
8,939
|
AMERICAN HEALTHCARE
REIT, INC.
Same-Store NOI
Reconciliation – (Continued)
For the Three Months
Ended March 31, 2024 and 2023
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
Total
|
|
|
|
NOI
|
$
82,177
|
|
$
66,885
|
Straight line
rent
|
(1,132)
|
|
(1,090)
|
Facility rental
expense
|
8,840
|
|
9,645
|
Other non-cash
adjustments
|
391
|
|
8,614
|
COVID
subsidies
|
—
|
|
(143)
|
Cash NOI attributable
to noncontrolling interest (1)
|
(12,714)
|
|
(10,789)
|
Cash NOI
|
$
77,562
|
|
$
73,122
|
Debt security
investment
|
(2,081)
|
|
(1,970)
|
New
acquisitions/dispositions/transitions
|
(4,135)
|
|
(7,897)
|
Development
conversion
|
540
|
|
412
|
Non-Core
Properties
|
(1,207)
|
|
(1,104)
|
Same-Store
NOI
|
$
70,679
|
|
$
62,563
|
|
|
|
|
|
|
|
|
(1)
|
All quarters are based
upon ownership percentage as of the most recent quarter
end.
|
AMERICAN HEALTHCARE
REIT, INC.
Same-Store Revenue
Reconciliation
For the Three Months
Ended and Years Ended March 31, 2024 and 2023
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
ISHC
|
|
|
|
GAAP revenue
|
$
393,122
|
|
$
361,770
|
Cash revenue
attributable to noncontrolling interest (1)
|
(96,569)
|
|
(88,867)
|
Cash revenue
|
$
296,553
|
|
$
272,903
|
Revenue attributable to
non-Same-Store properties
|
(93,786)
|
|
(84,108)
|
Same-Store
revenue
|
$
202,767
|
|
$
188,795
|
|
|
|
|
Outpatient
Medical
|
|
|
|
GAAP revenue
|
$
34,067
|
|
$
37,483
|
Straight line
rent
|
(158)
|
|
(393)
|
Other non-cash
adjustments
|
(185)
|
|
(119)
|
Cash revenue
|
$
33,724
|
|
$
36,971
|
Revenue attributable to
non-Same-Store properties
|
(155)
|
|
(3,983)
|
Revenue attributable to
Non-Core Properties
|
(1,266)
|
|
(1,149)
|
Same-Store
revenue
|
$
32,303
|
|
$
31,839
|
|
|
|
|
SHOP
|
|
|
|
GAAP revenue
|
$
58,996
|
|
$
46,860
|
Cash revenue
attributable to noncontrolling interest (1)
|
(276)
|
|
(379)
|
Cash revenue
|
$
58,720
|
|
$
46,481
|
Revenue attributable to
non-Same-Store properties
|
(16,053)
|
|
(7,613)
|
Revenue attributable to
development conversion
|
(270)
|
|
(591)
|
Same-Store
revenue
|
$
42,397
|
|
$
38,277
|
AMERICAN HEALTHCARE
REIT, INC.
Same-Store Revenue
Reconciliation – (Continued)
For the Three Months
Ended and Years Ended March 31, 2024 and 2023
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
Triple-Net Leased
Properties
|
|
|
|
GAAP revenue
|
$
13,348
|
|
$
6,113
|
Straight line
rent
|
(974)
|
|
(697)
|
Other non-cash
adjustments
|
210
|
|
8,468
|
Cash revenue
attributable to noncontrolling interest (1)
|
(186)
|
|
(182)
|
Cash revenue
|
$
12,398
|
|
$
13,702
|
Debt security
investment
|
(2,081)
|
|
(1,970)
|
Revenue attributable to
non-Same-Store properties
|
—
|
|
(1,805)
|
Revenue attributable to
Non-Core Properties
|
(458)
|
|
(477)
|
Same-Store
revenue
|
$
9,859
|
|
$
9,450
|
|
|
|
|
Total
|
|
|
|
GAAP revenue
|
$
499,533
|
|
$
452,226
|
Straight line
rent
|
(1,132)
|
|
(1,090)
|
Other non-cash
adjustments
|
25
|
|
8,349
|
Cash revenue
attributable to noncontrolling interest (1)
|
(97,031)
|
|
(89,428)
|
Cash revenue
|
$
401,395
|
|
$
370,057
|
Debt security
investment
|
(2,081)
|
|
(1,970)
|
Revenue attributable to
non-Same-Store properties
|
(109,994)
|
|
(97,509)
|
Revenue attributable to
development conversion
|
(270)
|
|
(591)
|
Revenue attributable to
Non-Core Properties
|
(1,724)
|
|
(1,626)
|
Same-Store
revenue
|
$
287,326
|
|
$
268,361
|
|
|
|
|
|
|
|
|
(1)
|
All quarters are based
upon ownership percentage as of the most recent quarter
end.
|
AMERICAN HEALTHCARE
REIT, INC.
Earnings Outlook
Reconciliation
For the Year Ending
December 31, 2024
(In millions, except
per share amounts) (Unaudited)
|
|
|
Low
|
|
High
|
Net (loss) income
attributable to common stockholders
|
$
(4.15)
|
|
$ 3.19
|
Depreciation and
amortization(1)
|
147.26
|
|
147.26
|
NAREIT FFO attributable
to common stockholders
|
143.11
|
|
150.45
|
|
|
|
|
Amortization of other
intangible assets(1)
|
$
1.66
|
|
$ 1.66
|
Change in deferred
rent(1)
|
(0.42)
|
|
(0.42)
|
Non-cash impact of
changes to equity plan(1)
|
6.04
|
|
6.04
|
Other
adjustments
|
(0.80)
|
|
(0.80)
|
Normalized FFO
attributable to common stockholders
|
$
149.58
|
|
$
156.92
|
|
|
|
|
Net (loss) income
per common share
|
$
(0.03)
|
|
$ 0.03
|
|
|
|
|
NAREIT FFO per
common share
|
$ 1.13
|
|
$ 1.19
|
|
|
|
|
Normalized FFO
per common share
|
$ 1.18
|
|
$ 1.24
|
|
|
|
|
Weighted average
diluted shares
|
126.6
|
|
126.6
|
|
|
|
|
Total Portfolio
Same-Store NOI growth
|
5.00 %
|
|
7.00 %
|
|
|
|
|
Segment-Level
Same-Store NOI growth:
|
|
|
|
ISHC
|
8.00 %
|
|
10.00 %
|
Outpatient
Medical
|
(0.50) %
|
|
0.00 %
|
SHOP
|
25.00 %
|
|
30.00 %
|
Triple-Net
Leased
|
1.00 %
|
|
3.00 %
|
|
|
|
|
|
|
|
|
(1)
|
Amounts presented net
of noncontrolling interests' share and AHR's share of
unconsolidated entities.
|
Definitions
Adjusted EBITDA: EBITDA excluding the impact of
stock-based compensation expense, acquisition and pursuit costs,
gain (loss) on sales of real estate, unrealized foreign currency
gain (loss), change in fair value of financial instruments,
impairment of real estate assets, lease termination revenue,
non-recurring items, and adjusted for non-controlling interest.
Cash NOI: NOI excluding the impact of, without
duplication, (1) non-cash items such as straight-line rent and the
amortization of lease intangibles, (2) third-party facility rent
payments and (3) other items set forth in the Cash NOI
reconciliation included herein. Both Cash NOI and Same-Store NOI
include ownership and other adjustments.
EBITDA: A non-GAAP financial measure that is defined as
earnings before interest, taxes, depreciation and amortization.
GAAP revenue: Revenue recognized in accordance with
Generally Accepted Accounting Principles ("GAAP"), which includes
straight line rent and other non-cash adjustments.
ISHC: Integrated senior health campuses include a range
of senior care, including independent living, assisted living,
memory care, skilled nursing services and certain ancillary
businesses. Integrated senior health campuses are predominantly
operated utilizing a RIDEA structure.
NAREIT FFO or FFO: Funds from operations attributable
to controlling interest; a non-GAAP financial measure, consistent
with the standards established by the White Paper on FFO approved
by the Board of Governors of NAREIT (the "White Paper"). The White
Paper defines FFO as net income (loss) computed in accordance with
GAAP, excluding gains or losses from sales of certain real estate
assets, gains or losses upon consolidation of a previously held
equity interest, and impairment write-downs of certain real estate
assets and investments, plus depreciation and amortization related
to real estate, after adjustments for unconsolidated partnerships
and joint ventures. While impairment charges are excluded from the
calculation of FFO as described above, investors are cautioned that
impairments are based on estimated future undiscounted cash flows.
Adjustments for unconsolidated partnerships and joint ventures are
calculated to reflect FFO.
Net Debt: Total long-term debt, excluding operating
lease liabilities, less cash and cash equivalents and restricted
cash pertaining to debt.
NOI: Net operating income; a non-GAAP financial measure
that is defined as net income (loss), computed in accordance with
GAAP, generated from properties before general and administrative
expenses, business acquisition expenses, depreciation and
amortization, interest expense, gain or loss on dispositions,
impairment of real estate investments, impairment of goodwill,
income or loss from unconsolidated entities, gain on re-measurement
of previously held equity interest, foreign currency gain or loss,
other income and income tax benefit or expense.
Non-Core Properties: Assets that have been deemed not
essential to generating future economic benefit or value to our
day-to-day operations and/or are projected to be sold.
Normalized FFO attributable to controlling interest or
NFFO: FFO further adjusted for the following items
included in the determination of GAAP net income (loss): expensed
acquisition fees and costs, which we refer to as business
acquisition expenses; amounts relating to changes in deferred rent
and amortization of above and below-market leases (which are
adjusted in order to reflect such payments from a GAAP accrual
basis); the non-cash impact of changes to our equity instruments;
non-cash or non-recurring income or expense; the noncash effect of
income tax benefits or expenses; capitalized interest; impairment
of goodwill; amortization of closing costs on debt investments;
mark-to-market adjustments included in net income (loss); gains or
losses included in net income (loss) from the extinguishment or
sale of debt, hedges, foreign exchange, derivatives or securities
holdings where trading of such holdings is not a fundamental
attribute of the business plan; after adjustments for consolidated
and unconsolidated partnerships and joint ventures, with such
adjustments calculated to reflect Normalized FFO on the same
basis.
Occupancy: With respect to OM, the percentage of total
rentable square feet leased and occupied, including month-to-month
leases, as of the date reported. With respect to all other property
types, occupancy represents average quarterly operating occupancy
based on the most recent quarter of available data. The Company
uses unaudited, periodic financial information provided solely by
tenants to calculate occupancy and has not independently verified
the information. Occupancy metrics are reflected at our Pro-Rata
share.
Outpatient Medical or OM: Outpatient Medical
buildings.
Pro-Rata: As of March 31,
2024, we owned and/or operated our 126 integrated senior
health campuses through entities of which we owned 75.4% of the
ownership interests and eight other buildings through entities of
which we owned 90.0% to 98.0% of the ownership interests. Because
we have a controlling interest in these entities, these entities
and the properties these entities own are consolidated in our
financial statements in accordance with GAAP. However, while such
properties are presented in our financial statements on a
consolidated basis, we are only entitled to our Pro-Rata share of
the net cash flows generated by such properties. As a result, we
have presented certain property information herein based on our
Pro-Rata ownership interest in these entities and the properties
these entities own, as of the applicable date, and not on a
consolidated basis. In such instances, information is noted as
being presented on a "Pro-Rata share" basis.
RIDEA: Used to describe properties within the portfolio
that utilize the RIDEA structure as described in "RIDEA
structure".
RIDEA structure: A structure permitted by the REIT
Investment Diversification and Empowerment Act of 2007, pursuant to
which we lease certain healthcare real estate properties to a
wholly-owned taxable REIT subsidiary ("TRS"), which in turn
contracts with an eligible independent contractor ("EIK") to
operate such properties for a fee. Under this structure, the EIK
receives management fees, and the TRS receives revenue from the
operation of the healthcare real estate properties and retains, as
profit, any revenue remaining after payment of expenses (including
intercompany rent paid to us and any taxes at the TRS level)
necessary to operate the property. Through the RIDEA structure, in
addition to receiving rental revenue from the TRS, we retain any
after-tax profit from the operation of the healthcare real estate
properties and benefit from any improved operational performance
while bearing the risk of any decline in operating performance at
the properties.
Same-Store or SS: Properties owned and consolidated the
full period in both comparison periods and that are not otherwise
excluded. Properties are excluded from Same-Store if they are: (1)
sold, classified as held for sale or properties whose operations
were classified as discontinued operations in accordance with GAAP;
(2) impacted by materially disruptive events, such as flood or fire
for an extensive period of time; or (3) scheduled to undergo or
currently undergoing major expansions/renovations or business model
transitions or have transitioned business models after the start of
the prior comparison period.
Same-Store NOI or SS NOI: Cash NOI for our Same-Store
properties. Same-Store NOI is used to evaluate the operating
performance of our properties using a consistent population which
controls for changes in the composition of our portfolio. Both Cash
NOI and Same-Store NOI include ownership and other adjustments.
SHOP: Senior housing operating properties.
Square Feet or Sq. Ft.: Net rentable square feet calculated
utilizing Building Owners and Managers Association measurement
standards.
Total Debt: The principal balances of the Company's
revolving credit facility, term loans and secured indebtedness as
reported in the Company's consolidated financial statements.
Trilogy: Trilogy Investors, LLC; one of our
consolidated joint ventures, in which we indirectly owned a 75.4%
interest as of March 31, 2024.
Trilogy REIT Holdings: Trilogy REIT Holdings, LLC; the
joint venture between the Company and NorthStar Healthcare Income,
Inc. that owns the interest in Trilogy or Trilogy Investors,
LLC.
Triple-net leased: A lease where the tenant is
responsible for making rent payments, maintaining the leased
property and paying property taxes and other expenses.
Contact: Alan
Peterson
Email:
investorrelations@ahcreit.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/american-healthcare-reit-ahr-announces-first-quarter-2024-results-302143810.html
SOURCE American Healthcare REIT, Inc.